Page last updated: 2024-11-01

masoprocol and Stroke

masoprocol has been researched along with Stroke in 2 studies

nordihydroguaretic acid: antioxidant compound found in the creosote bush (Larrea tridentata)

Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chioua, M1
Sucunza, D1
Soriano, E1
Hadjipavlou-Litina, D1
Alcázar, A1
Ayuso, I1
Oset-Gasque, MJ1
González, MP1
Monjas, L1
Rodríguez-Franco, MI1
Marco-Contelles, J1
Samadi, A1
Rai, G1
Joshi, N1
Jung, JE1
Liu, Y1
Schultz, L1
Yasgar, A1
Perry, S1
Diaz, G1
Zhang, Q1
Kenyon, V1
Jadhav, A1
Simeonov, A1
Lo, EH1
van Leyen, K1
Maloney, DJ1
Holman, TR1

Other Studies

2 other studies available for masoprocol and Stroke

ArticleYear
Α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties.
    Journal of medicinal chemistry, 2012, Jan-12, Volume: 55, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Blood-Brain Barrier; Cell Hypoxia; C

2012
Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies.
    Journal of medicinal chemistry, 2014, May-22, Volume: 57, Issue:10

    Topics: Animals; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; High-Throughput Screening Assay

2014